ANEB OTC
Anebulo Pharmaceuticals, Inc.
1W: -1.5%
1M: +6.7%
3M: -13.0%
YTD: -71.7%
1Y: -86.7%
3Y: -90.2%
5Y: -95.4%
$0.32
+0.00 (+0.00%)
Weekly Expected Move ±12.6%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-8M
Net Income
-4.1% YoY
$-6M
Free Cash Flow
+12.1% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-69.7%
ROA-63.2%
ROIC650.7%
Valuation
P/E-2.1
P/B1.7
EV/EBITDA-4.2
Leverage
Debt/Equity0.00
Current Ratio16.71
Interest Cov.-25.8x
Quality Scores
Piotroski F1/9
Altman Z3.58
Beneish M0.00